Iradimed Corp
(IRMD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | 2,050 | 1,937 | 966 | N/A |
| Depreciation Amortization | 149 | 139 | 106 | N/A |
| Accounts receivable | 131 | -397 | -1,154 | N/A |
| Accounts payable and accrued liabilities | 202 | 19 | 337 | N/A |
| Other Working Capital | -124 | -874 | 264 | N/A |
| Other Operating Activity | 178 | 650 | 990 | 0 |
| Operating Cash Flow | $2,586 | $1,474 | $1,509 | $N/A |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | -7,696 | -5 | -5 | N/A |
| PPE Investments | -606 | -192 | -113 | N/A |
| Purchase Sale Intangibles | N/A | 0 | -49 | N/A |
| Other Investing Activity | 0 | 0 | -49 | 0 |
| Investing Cash Flow | $-8,303 | $-197 | $-166 | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 14,595 | N/A | N/A | N/A |
| Other Financing Activity | -1,885 | -513 | -239 | 0 |
| Financing Cash Flow | $12,710 | $-513 | $-239 | $N/A |
| Beginning Cash Position | 2,462 | 1,697 | 593 | N/A |
| End Cash Position | 9,454 | 2,462 | 1,697 | N/A |
| Net Cash Flow | $6,993 | $764 | $1,104 | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | 2,586 | 1,474 | 1,509 | N/A |
| Capital Expenditure | -606 | -192 | -113 | N/A |
| Free Cash Flow | 1,979 | 1,283 | 1,396 | 0 |